The Combination of Dupilumab with Other Monoclonal Antibodies
ConclusionsBecause the evidence is modest, the question remains open as to whether dupilumab can be safely combined with other monoclonal antibodies. Dupilumab does not exert immunosuppressive effects and does not impair the activity of cytochrome P450 isozymes.
Source: Dermatology and Therapy - Category: Dermatology Source Type: research
More News: Abatacept | Ankylosing Spondylitis | Arthritis | Asthma | Cancer & Oncology | Carcinoma | Crohn's Disease | Dermatitis | Dermatology | Erbitux | Hidradenitis | Hives | Humira | Orencia | Pemphigoid | Psoriasis | Psoriatic Arthritis | Rheumatoid Arthritis | Rheumatology | Skin | Xolair